Market Scope uses a multi-source methodology when preparing our annual and quarterly reports. We incorporate surgeon surveys, our extensive database of physicians and surgery centers, disease models, clinical studies, financial reports, and more. Our wide-ranging knowledge of products and technology and our comprehensive network of industry contacts also contribute to our coverage on the ophthalmic and orthopedic industries.
Market Scope’s 2020 Ophthalmic Laser Market Report provides in-depth coverage of treatments, manufacturers, and technologies impacting the market. Our analysis includes market data for 2019 and forecasts performance through 2025. The report covers photocoagulation, photodisruption, and SLT lasers. We forecast product demand in units and dollars, and we analyze market shares by product category.
This report is designed for ophthalmic industry manufacturers, market analysts, providers, and investors who are interested in the ophthalmic lasers business and related products. In-depth topics include laser treatment estimates, ophthalmic surgeons using lasers, and manufacturers of ophthalmic lasers (excluding femtosecond and excimer).
Our coverage of the refractive surgery market includes a quarterly surveying process that targets and collects data from US refractive surgeons. The resulting data are analyzed and presented in our US Refractive Surgery Quarterly Updates. These updates are designed to improve your decision-making process with the most accurate assessment of current market conditions and the identification of significant market trends.
Since 2001, Market Scope has conducted annual surveys of US cataract surgeons on important issues regarding practice characteristics, product preferences, surgical techniques, and practice marketing. Our survey highlights practice patterns regarding presbyopic-correcting IOLs (PC-IOLs), toric IOLs, extended depth of focus (EDOF) IOLs, correction of astigmatism, femtosecond laser-assisted cataract surgery (FLACS), sugical location, interest in upcoming technology, equipment use, treatment and management of glaucoma and micro-invasive glaucoma survery (MIGS) devices and much more. We also measure market share by manufacturer, product, and market segment. Leading ophthalmic firms and organizations sponsor the survey in order to better understand industry dynamics and gain important insights into surgeons’ experiences and preferences, as well as emerging trends. We surveyed using paper surveys mailed to cataract surgeons and online to surgeons registered on our website.
The 2020 India Ophthalmic Market Report analyzes the current landscape of the Indian ophthalmic market, discussing important trends and key factors for future success, and includes forecasts of disease prevalence, numbers of treatments, and technologies used in treatments.
The 2020 United States Refractive Atlas provides a geographic analysis of the US refractive market in 85 metropolitan areas. Market Scope’s MedOp Index™ Analysis is used to identify the potential for refractive surgery and considers many factors for each geography including: population age distribution, refractive error, income/buying power, overall health, education level, and location of refractive surgeons and LVC centers. High-opportunity populations and benchmarking comparisons are provided for each metropolitan area. Additionally, the atlas provides a comprehensive directory of US refractive surgeons. Market Scope also offers customization of atlas data to align with sales territories or specific geographic areas.
Market Scope surveyed 105 ophthalmologists and orthopedic surgeons on March 24, 2020, to measure the impact of COVID-19 on their surgical practices and perceptions on how long the effects of the pandemic would impact their practice. The results of this survey are included in this report, which is being offered free of charge as a courtesy to our clients.
Knee arthroplasty is a major source of revenue for the orthopedic market. Global demand for knee procedures is rising alongside expanding elderly populations and increased access to care in historically underserved countries. New technology and innovative implant designs promise to shift the cost-benefit ratio of the procedures, which coincides with pressure from global health care system to decrease costs. However, the COVID-19 pandemic will greatly impact the market landscape in 2020.
This report provides an in-depth analysis of the global knee arthroplasty market with forecasts through 2025. It is designed for manufacturers, providers, market analysts, and investors who are interested in the market and related products.
Our coverage of the knee surgery market includes a quarterly surveying process that targets and collects data from US knee surgeons. The resulting data are consolidated with industry and provider data and extrapolated to market, then analyzed and presented in our US Knee Surgeon Survey Reports. These quarterly reports are designed to improve your decision-making process with an assessment of current market conditions and the identification of significant market trends, including a variety of vital practice of medicine issues, product use and market share, doctors’ evaluations of surgical equipment, and product adoption plans.
Each update includes full-year forecasts, comparisons with prior years, and trend analysis.
The United States Cataract Atlas provides a geographic analysis of the conventional and premium cataract surgery opportunity in 85 US metropolitan areas. Market Scope’s proprietary MedOp Index™ Analysis examines market potential and provides a benchmark against other metros. The Cataract Atlas offers strategic insights into the top potential markets in the US.
The 2020 Glaucoma Pharmaceuticals Market Report is Market Scope’s comprehensive analysis of the glaucoma pharmaceutical segment of ophthalmology. Our report is designed for members of the ophthalmic industry who participate in this market or are weighing doing so, market analysts, ophthalmologists who treat glaucoma patients, investors, and anyone else who might be interested in the global marketplace of glaucoma pharmaceuticals.
A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.